069620.KS
Daewoong pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 114,800.00
−7.49%Leverage
- Debt / equity
- 0.87x
- Net debt / equity
- 0.72x
- Debt / assets
- 0.36x
- Debt / EBITDA
- 3.62x
- Net debt / EBITDA
- 3.01x
Liquidity & coverage
- Current ratio
- 0.89x
- Quick ratio
- 0.52x
- Cash ratio
- 0.18x
- Interest coverage
- 13.01x
- EBITDA / interest
- 17.46x
- Working capital
- -KRW 98.8B
Cash & dividend
- FCF / debt
- -0.13x
- Cash flow / debt
- 0.18x
- Dividend per share
- KRW 600
- Dividend yield
- 0.5%
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026